Skip to content

Intravenous Subdissociative-dose Ketamine Versus Morphine for Prehospital Analgesia

Intravenous Subdissociative-dose Ketamine Versus Morphine for Prehospital Analgesia a Randomized Controlled Trial

Status
Terminated
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03236805
Acronym
KETAMORPH
Enrollment
285
Registered
2017-08-02
Start date
2017-11-23
Completion date
2022-11-26
Last updated
2022-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain Management

Keywords

Morphine, Ketamine, Acute pain, prehospital

Brief summary

This is a prospective, randomized, single-blind trial evaluating prehospital patients experiencing moderate to severe acute pain, defined as a numeric rating scale score greater than or equal to 5. Patients will be randomized to receive ketamine at or morphine by intravenous push.

Detailed description

This study is designed to evaluate if ketamine alone is non inferior to morphine alone for prehospital analgesia. Numeric rating scale pain scores will be compared between recipients of ketamine and recipients of morphine at 15, 30, 45 and 60 min post first injection and at hospital admission.

Interventions

DRUGKetamine

Initial bolus of 20 mg (around 0.3 mg per kg) followed by bolus of 10 mg every 5 minutes as reported by the recommandations of experts of the french society of urgency care

DRUGMorphine

Bolus of 2 mg (patient with weight under 60 kgs) or bolus of 3 mg (patient with weight above 60 kgs) every 5 minutes as reported by the recommandations of experts of the french society of urgency care

Sponsors

Nantes University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* older than 18 years old * prehospital moderate to severe acute pain, defined as a numeric rating scale score greater than or equal to 5

Exclusion criteria

* unstable vital signs (systolic blood pressure \<90 or \>200 mm Hg, pulse rate \<50 or \>150 beats/min, and respiration rate \<10 or \>30 breaths/min) * pregnancy * breast-feeding * altered mental status * unable to give numeric rating scale scores * allergy to morphine or ketamine * acute pulmonary edema * acute coronary syndrome * renal or hepatic insufficiency * patient who received morphine for the same acute pain * acute psychiatric illness

Design outcomes

Primary

MeasureTime frame
Comparison of numeric rating scale pain scores between recipients of ketamine and morphine at 30 minutes post first injection.30 minutes

Secondary

MeasureTime frame
Comparison of numeric rating scale pain scores between recipients of ketamine and morphine at 15 minutes post first injection.15 minutes
Comparison of numeric rating scale pain scores between recipients of ketamine and morphine at 45 minutes post first injection.45 minutes
Comparison of numeric rating scale pain scores between recipients of ketamine and morphine at 60 minutes post first injection.60 minutes

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026